# A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

> **NCT04115345** · PHASE1 · COMPLETED · sponsor: **Prokidney** · enrollment: 6 (actual)

## Conditions studied

- Chronic Kidney Disease
- Congenital Anomalies of Kidney and Urinary Tract

## Interventions

- **BIOLOGICAL:** Renal Autologous Cell Therapy (REACT)

## Key facts

- **NCT ID:** NCT04115345
- **Lead sponsor:** Prokidney
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-13
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115345, "A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04115345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*